Mayne Pharma Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Adelaide Australia (1845)

Organization Overview

First Clinical Trial
2008
NCT00791219
First Marketed Drug
1981
erythromycin (ilosone)
First NDA Approval
2021
estetrol (NEXTSTELLIS)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Halcygen Pharmaceuticals Limited | MAYNE PHARMA | MAYNE PHARMA COMMRCL | MAYNE PHARMA INC | Mayne Pharma International Pty Ltd | MAYNE PHARMA INTL